Additional European Equity News

Admiral (ADM LN) - H1 (GBP): PBT 309.8mln (prev. 233.9mln Y/Y), EPS 77.5p (prev. 57.6p Y/Y). No shares exp. to be repurchased until 2026. (Newswires) 

AstraZeneca (AZN LN) - Imfinzi granted Priority Review and Breakthrough Therapy Designation for patients with limited-stage small cell lung cancer in the US. (AstraZeneca)

Adyen (ADYEN NA) - H1 (EUR): EBITDA 423.1mln (exp. 413.2mln), Net Income 913.4mln (exp. 922.5mln). Continues to expect to be towards low end of 2026 range. (Newswires)

EQT (EQT SS) - Co. is planning to raise USD 12.5bln for its next Asia fund, which would be one of the largest private equity funds in the region, according to Bloomberg. (Bloomberg)

Fortum (FORTUM FH) - Q2 (EUR): Sales 1.25bln (exp. 1.16bln), Adj. EBITDA 326mln (exp. 308.3mln). (Newswires) 

NatWest (NWG LN) - Texas has added the bank to a list of firms that "boycotts" energy companies, which could see the bank's business with public agencies be restricted. (Newswires)

Oersted (ORSTED DC) - Q2 (DKK): EBITDA 5.27bln (prev. 3.32bln Y/Y), FCF 6.08bln (prev. 2.44bln Y/Y). Outlook: Maintain EBITDA guidance. Increased directional guidance in offshore and decreased in bioenergy & other. Books DKK 3.9bln in impairment losses, due partly to a delay in a wind project. (Newswires)

OSB Group (OSB LN) - Downgraded NIM for 2024. (Newswires)

15 Aug 2024 - 07:08- Research Sheet- Source: Newsquawk